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Due to inconsistent power supply in the developing countries, particularly in the rural areas, immediate 
sample separation and analysis may not be practicable. This study investigated the time-related changes 
in glucose concentration of serum and plasma specimens stored at 4oC and room temperature (32oC) for 
3 days. Blood samples were collected from 30 fasting patients suffering from diabetes mellitus at the 
Ebonyi State University Teaching Hospital (EBSUTH), Abakaliki, Nigeria. Glucose levels were assayed 
using glucose oxidase method immediately upon sample collection and separation to obtain the baseline 
value (BV) and thereafter at specified time intervals across 72 hours. In serum samples, the values 
obtained after 2 hours at 32oC and at the 72nd hour at 4oC were significantly different (P<0.05) from the 
baseline value (BV) while for the plasma specimens, the values differed significantly (P<0.05) from the BV 
after 6 hours at 32oC. The plasma glucose level was found to be stable throughout the storage period of 3 
days at 4oC. Also, glucose concentration was found to be more stable in refrigerated samples than in 
those kept at ambient temperature (32oC). Based on the findings of this study, reliable values for serum 
glucose can be obtained from samples kept at room temperature only if analysis is carried out within 2 
hours of sample collection. However, when refrigerated, serum glucose results could still be relied upon 
for diagnosis if carried out within 48 hours post collection. Otherwise, plasma specimens are 
recommended for glucose estimation if little delay before analysis is anticipated since glucose was 
found to be more stable in plasma samples obtained from sodium fluoride anticoagulated blood. 
 




Diabetes mellitus is a metabolic disease that results 
from absolute or relative deficiency of insulin, 
characterized by persistent increase in blood 
glucose levels above normal termed hyperglycemia 
and its attendant complications (Grundy et al., 
1999). The population of people with diabetes 
mellitus, sometimes known as “the silent killer” is 
increasing at an alarming rate yearly. In Britain for 
instance, the population of elderly people with non-
insulin dependent diabetes mellitus is estimated at 
between 3-6% (Heil et al., 1987; Croxson et al., 
1991). Nearly two decades ago, it was recognized 
in Britain that diabetes was neglected and that 
many patients were being denied specialist care. 
Several community studies of diabetes have also 
shown that these patients suffer a disproportionate 
burden of ill health and are responsible for 
increased economic and social demands on society 
(Alberti, 1991). 
 Management of diabetes mellitus includes 
assessing the impact of co-existing diseases and 
maintaining the patient’s well being and quality of 
life. More emphasis, however, should be placed on 
laboratory tests, which require the co-operation of 
all medical personnel. Currently in medical practice 
a diagnosis of diabetes mellitus is not considered 
definitive or complete until information obtained 
from the patient’s history and clinical examination 
are matched with the results of blood glucose 
estimations (Boulton, 1992). The results of blood 
glucose determinations can be strongly affected by 
the method of storage and handling of the blood 
samples between the time of collection and the time 
of analysis (Young and Bermes, 1999). Improperly 
handled or stored samples could generate results 
that may mislead the clinician into wrong 
judgment/diagnosis (Clark et al., 2003). As a result, 
the major challenge faced by clinical laboratories 
worldwide is ensuring the integrity and reliability of 
laboratory results. In addition to pathological 
processes, laboratory results are affected by certain 
pre-analytical, analytical and normal biological 
variations. But as analytical variations are being 
reasonably minimized by the development of new 
techniques, the relative contribution of preanalytical 
factors to spurious results has becomes a more 
dominant element in overall test variability 
(Navayanan, 1995; Young and Bermes, 1999). 
 Since prolonged contact of plasma or 
serum with cells is a common cause of spurious test 
results, plasma and serum should ideally be 
separated from cells as quickly as possible to 
prevent on going metabolism of cellular constituents 
as well as active and passive movement of analytes 
between the plasma or serum and cellular 
compartments (Ono et al., 1981; Murphy et al., 
2000). Standard guidelines for blood sample 
handling and processing states that serum or 
plasma should be physically separated from contact 
with cells as soon as possible unless conclusive 
evidence shows that longer contact times do not 
contribute to result inaccuracy. A maximum time of 
two hours from the time of sample collection to the 
time of separation of serum and plasma from cells 
was also recommended (NCCLS Infobase, 1995; 
Young and Bermes, 1999). 
 It is generally recommended that glucose 
estimations in serum and plasma samples be 
carried out immediately upon sample collection, and 
if not immediately possible, that the specimens 
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should be kept frozen until when the determinations 
are possible, but certainly within 24 hours 
(Nakashima et al., 1987; Young and Bermes, 1999). 
There is limited evidence though to suggest that 
serum and plasma glucose may not be stable when 
samples are kept for several hours or even days at 
ambient temperature condition. Due to a variety of 
experimental designs and variations in the ambient 
temperature conditions in different localities, the 
available reports regarding the stability of serum 
and plasma glucose at room/ambient temperature 
are, however conflicting. 
 In a developing country like ours, 
laboratory personnel are constantly faced with the 
problems of inconsistent power supply such that 
specimens for analysis are left on the laboratory 
bench at ambient temperature for several hours or 
even days before analysis can be done. In this 
study, we applied routine laboratory tests to 
investigate the changes in glucose levels in serum 
and plasma samples stored at 4oC and 32oC for a 
period of 3 days. 
 
Materials and Methods 
 
10ml of blood was collected by venepuncture 
between 8-10 hours from 40 fasting patients 
diagnosed with diabetes mellitus at the Ebonyi 
State University Teaching Hospital (EBSUTH), 
Abakaliki, Nigeria after their oral informed consent 
was obtained. The blood samples were dispensed 
into each of the following collection tubes (a) half 
was added into a specimen bottle containing 
appropriate quantity of sodium fluoride and 
potassium oxalate (fluoride oxalate bottle) and (b) 
the other half was put  into a clean dry pla n bottle. 
The sample added into the fluoride oxalate bottle 
was centrifuged immediately after collection (3000 
rpm for 5 minutes) and the plasma from it 
dispensed into a clean dry plain bottle. The sample 
collected into the clean dry plain bottle was allowed 
to stand at room temperature for 15 minutes to clot 
after which it was centrifuged at 3000 rpm for 5 
minutes and the serum from it separated into 
another clean dry plain bottle. 
i 
 The serum and plasma samples from each 
patient were analyzed in duplicates immediately 
after separation from clot/blood cells to obtain the 
baseline fresh values against which other 
concentrations of future time-points were compared. 
The plasma and serum samples were then divided 
into two equal parts. One part was kept in a 
refrigerator at 4oC, while the other was kept on the 
laboratory bench at room temperature (range of 30-
34oC, average of 32oC). Further analysis on the 
samples were carried out in duplicates at 2 –hour 
intervals for the first 12 hours, then at 4 –hour 
intervals for another 12 hours, and later at 6-hour 
intervals for 24 hours and finally once after another 
24 hours giving a total period of 3 days. 
 Glucose concentrations in the serum and 
plasma samples were determined by the glucose 
oxidase method (Washko and Rice, 1961). All 
determinations were carried out in duplicates each 
time and the average of the two results calculated. 
Results obtained from subsequent determinations 
were compared with the baseline fresh values. The 
influence of storage time and temperature on the 
measured quantity was examined using the repeat 
measure analysis of variance (ANOVA). The 
changes occurring on storage were calculated for 
glucose for individual patient and the result was 
expressed as a percentage of the initial value. 
Instability was defined as a change of 10% or more 
from the initial value provided ANOVA test was 
statistically significant (P<0.05). A difference of 10% 
was selected because changes of less than this are 
unlikely to be clinically significant. The results 
obtained from the samples kept at 4oC were also 
compared with that obtained from samples kept at 
32oC at each point of determination using student’s 
t-test. Also, the serum and plasma results per unit 
time were compared with each other using the 
student’s t-test. In this paper, the results are 
presented as mean percentage changes from the 
baseline value. The negative signs show 




Table 1 shows the results obtained with serum 
samples separated immediately from clot and kept 
at both 4oC and 32oC. On the whole, the glucose 
levels in the serum samples showed a decrease 
across the period of storage from the baseline value 
(zero hour) to the 72nd hour when specimens were 
stored at both temperature conditions. The mean 
glucose concentration was stable for 48 hours when 
samples were kept at 4oC. At ambient temperature, 
significantly lower (P<0.05) values from the 
baseline value were observed from the second hour 
of sample storage. 
Table 1: The percentage change in glucose 
concentration in serum samples stored at varied 
temperature conditions 




serum (4oC) serum (32oC) 
2 -1.3    ±   0.06 -10.2    ± 0.65 
4 -1.9   ±   0.24 -11.1    ± 0.76 
6 -2.6   ±   1.01 -11.9   ± 0.54 
8 -3.4   ±   0.75 -13.1   ± 0.92 
10 -4.1   ±   2.00 -13.7   ± 1.24 
12 -4.8   ±   0.71 -15.2   ± 1.05 
16 -5.7   ±   2.65 -15.8   ± 0.76 
20 -6.1   ±   2.29 -16.6   ± 1.90 
24 -6.9   ±   0.69 -18.3   ± 2.00 
30 -7.5   ±   1.37 -18.9   ± 0.81 
36 -7.8   ±   0.81 -19.4   ± 1.01 
42 -8.1   ±   0.95 -19.9   ± 0.91 
48 -8.4   ±   1.41 -20.8   ± 2.56 
72 -10.5 ±   1.54 -23.4  ±  2.19 
 
The glucose concentration in the plasma samples 
also showed a decrease across the period of 
storage from the baseline value (zero hour) to the 
72nd hour (Table 2). Statistical analysis showed 
that when plasma was kept at 4oC, the mean 
glucose level was stable throughout the duration of 
the study. However, significant changes (P<0.05) 
were observed from the 6th hour of storage when 
plasma samples were kept at ambient temperature. 
 




Table 2: The percentage change in glucose 
concentrations in plasma samples stored at 
varied temperature conditions 




plasma (4oC) plasma (32oC) 
2 -0.2    ±   0.10 -6.9    ± 0.18 
4 -0.9   ±   0.25 -8.5    ± 0.15 
6 -1.1   ±   1.40 -10.6  ± 0.49 
8 -1.3   ±   0.38 -11.4   ± 0.46 
10 -1.5   ±   0.06 -12.5   ± 0.46 
12 -1.8   ±   0.23 -13.2   ± 1.03 
16 -2.5   ±   0.41 -13.9   ± 1.74 
20 -2.9   ±   0.54 -14.7   ± 0.69 
24 -3.3   ±   1.21 -15.8   ± 0.31 
30 -4.1   ±   1.03 -16.5   ± 0.59 
36 -4.7   ±  0.54 -16.9   ± 0.88 
42 -5.4   ±  0.98 -17.4   ± 2.07 
48 -5.8  ±   1.02 -17.8   ± 2.11 




This study was conducted to determine the effects 
of storage temperature and time on the 
concentration of glucose in serum and plasma 
samples. The anticoagulant selected is the one 
commonly used in the determination of blood 
glucose levels. The present work demonstrates that 
glucose can be measured reliably in serum samples 
kept at room temperature if the assay is carried out 
within 2 hours of specimen collection and serum 
separation. Serum glucose level exhibit greater 
stability when samples are kept at 4oC, hence 
reliable quantification of this analyte can still be 
carried out within 48 hours if serum is stored in the 
refrigerator. In plasma, reliable quantification of 
glucose requires that analysis be carried out within 
six hours of sample collection and plasma 
separation if the specimen is kept at ambient 
temperature condition. However, storing samples at 
4oC showed that glucose level was stable 
throughout the duration of the study. 
 Previous researchers have studied the 
stability of clinical chemistry analytes in blood 
samples kept at different temperature conditions 
and different time-points. Investigating the effects of 
storage at refrigerator condition (4-5oC) and room 
temperature (23-25oC) on various biochemical 
constituents of camel sera, Saeed et al (1995) 
reported that at 4-5oC, glucose in camel sera 
remained stable up to 6 days of keeping while at 
room temperature (23-25oC), significant changes in 
glucose concentration occurred after 3 days. The 
study design was similar to that of the present work, 
with serum and plasma samples aliquoted 
immediately from clot/cells and stored under each 
temperature conditions up to the appropriate time 
before analysis. 
 In general, the outcome of this study has 
shown that reliable results for glucose assay can be 
obtained from both serum and plasma samples 
stored at both 4oC and 32oC for definite storage 
durations, with the refrigerated samples being more 
stable than the samples stored at 32oC. The greater 
stability of glucose in refrigerated samples when 
compared to those kept at room temperature is in 
agreement with earlier reports on related studies 
though the room temperature of storage in these 
studies differ (Ono et al., 1981; Rehak and Chiang, 
1988; Heins et al., 1995; Saeed et al.,1995; Dongbo 
et al., 1998; Bobby et al., 2002; Clark et al., 2003). 
 Again, glucose concentration decreased 
with increasing serum-clot / plasma-clot contact 
time (Bobby et al., 2002). It is well documented that 
glycolysis in cells consume glucose and cause a 
decrease in its level in blood during storage with a 
net gain in lactate and potassium ion concentrations 
in serum and plasma (Sunderman et al., 1956). As 
a result, Thoresen et al (1992) strongly 
recommended the practice of separating serum and 
plasma from clot / cells as promptly as possible to 
achieve improved stability of most analytes under 
test. 
 It can also be observed from this study that 
for both storage temperatures, the concentration of 
glucose in plasma was more stable than that 
observed for serum samples. This is in agreement 
with an earlier work by Chan et al (1989) who 
reported that glycolysis can be inhibited and 
glucose concentration stabilized by the use of 
sample collection tubes containing sodium fluoride 
as an additive. Thus, plasma is a preferred sample 
for glucose determination particularly when delay is 
inevitable. 
 In conclusion, it can thus be generally 
advised based on the results of this work that in 
order to obtain reliable results for blood glucose 
determination, serum samples stored at 4oC should 
be assayed within 72 hours of blood collection while 
for those stored at 32oC analysis should be carried 
out within 2 hours otherwise, the use of plasma 
samples is recommended if little delay before 
analysis is anticipated. Finally, recording the length 
of time from sample collection to analysis might 
allow appropriate adjustment to be made for the 
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